The Use of Intravesical BCG in Urothelial Carcinoma of the Bladder

ecancermedicalscience - United Kingdom
doi 10.3332/ecancer.2019.905
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ecancer Global Foundation

Related search

Bilateral Uveitis After Intravesical BCG Immunotherapy for Bladder Carcinoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2002English

Cadmium in Urothelial Carcinoma of the Bladder

Polish Journal of Pathology
MedicineForensic MedicinePathology
2014English

CD10 Expression in Urothelial Carcinoma of the Bladder

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2009English

Intravesical Administration of Misonidazole in Bladder Carcinoma

Acta Radiologica: Oncology
1983English

Urothelial Carcinoma of the Bladder in a Pediatric Patient

Canadian Urological Association Journal
Urology
2016English

Urothelial Carcinoma of the Bladder and the Rise of Immunotherapy

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2017English

Old Instillations and New Implications in Bladder Cancer: The Urinary Microbiome and Intravesical BCG

BJU International
Urology
2019English

A Possible Mechanism of Intravesical BCG Therapy for Human Bladder Carcinoma: Involvement of Innate Effector Cells for the Inhibition of Tumor Growth

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2009English

587 Loss of BCG Viability Adversely Affects the Direct Response of Urothelial Carcinoma Cells to BCG Exposure

Journal of Urology
Urology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy